Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing

Niels W.C.J. van de Donk, MD, PhD, Henk M. Lokhorst, MD, Maarten Emmelot, Tineke Aarts-Riemens, Douglas W. McMillin, PhD, Gullu Gorgun, PhD, Steffen Klippel, PhD, Eugen Dhimolea, PhD, Jana Jakubikova, PhD, Catriona A. Hayes, MD, Panisinee Lawasut, MD, Jake E Delmore, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD, PhD, Tuna Mutis, MD PhD

Blood (2011) 118 (21): 1838.

https://doi.org/10.1182/blood.V118.21.1838.1838

Published: 2011

Journal Articles

Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial

Evelien Kneppers, Bronno van der Holt, Marie-Jose Kersten, Sonja Zweegman, Ellen Meijer, Gerwin Huls, Jan J. Cornelissen, Jeroen J. Janssen, Cynthia Huisman, Petra B. Cornelisse, Cheryl P. Bruijnen, Maarten Emmelot, Pieter Sonneveld, Henk M. Lokhorst, Tuna Mutis, Monique C. Minnema

Blood (2011) 118 (9): 2413–2419.

https://doi.org/10.1182/blood-2011-04-348292

Published: 2011

Journal Articles

Bone Marrow Neutralizes Human Regulatory T-Cells to Permit Graft-Versus-Tumor Immunity In Humanized Mice

Teun Guichelaar, PhD, Henk Rozemuller, PhD, Maarten Emmelot, Bianka Martini, Gert Storm, Henk M Lokhorst, MD, PhD, Anton Martens, PhD, Tuna Mutis, MD, PhD

Blood (2010) 116 (21): 1017.

https://doi.org/10.1182/blood.V116.21.1017.1017

Published: 2010

Journal Articles

Lenalidomide Is Highly Effective in Patients with Relapsed Multiple Myeloma Following Allogeneic Stem Cell Transplantation and Increases the Frequency of CD4 + FOXP3 + T Cells.

Monique C. Minnema, MD, Michael van der Veer, Tineke Aarts, Maarten Emmelot, Tuna Mutis, PhD, Henk M. Lokhorst, MD

Blood (2007) 110 (11): 2722.

https://doi.org/10.1182/blood.V110.11.2722.2722

Published: 2007

Journal Articles

Generation of CD4 + Regulatory T Cells by Retroviral Transduction of CD4 + CD25 − T Cells Either with the Full-Length or with a Common Exon-2 Negative Variant of Human Foxp3.

Tuna Mutis, MD, PhD, Leo F. Verdonck, MD, PhD, Tineke Aarts-Riemens, Maarten Emmelot

Blood (2005) 106 (11): 3315.

https://doi.org/10.1182/blood.V106.11.3315.3315

Published: 2005

Journal Articles

Human CD4 + CD25 + Regulatory T Cells Effectively Control Xenogeneic-GvHD Induced by Autologous T Cells in Rag2 −/− γc −/− Immune-Deficient Mice.

Tuna Mutis, MD, PhD, Rozemarijn S. van Rijn, MD, Elles R. Simonetti, Tineke Aarts, Maarten Emmelot, Saskia B. Ebeling, PhD

Blood (2004) 104 (11): 301.

https://doi.org/10.1182/blood.V104.11.301.301

Published: 2004

NARROW

Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing

Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial

Bone Marrow Neutralizes Human Regulatory T-Cells to Permit Graft-Versus-Tumor Immunity In Humanized Mice

Lenalidomide Is Highly Effective in Patients with Relapsed Multiple Myeloma Following Allogeneic Stem Cell Transplantation and Increases the Frequency of CD4 + FOXP3 + T Cells.

Generation of CD4 + Regulatory T Cells by Retroviral Transduction of CD4 + CD25 − T Cells Either with the Full-Length or with a Common Exon-2 Negative Variant of Human Foxp3.

Human CD4 + CD25 + Regulatory T Cells Effectively Control Xenogeneic-GvHD Induced by Autologous T Cells in Rag2 −/− γc −/− Immune-Deficient Mice.

Email alerts

ASH Publications

American Society of Hematology

Proteasome Inhibitors Sensitize Myeloma Cells to T Cell-Mediated Killing

Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial

Bone Marrow Neutralizes Human Regulatory T-Cells to Permit Graft-Versus-Tumor Immunity In Humanized Mice

Lenalidomide Is Highly Effective in Patients with Relapsed Multiple Myeloma Following Allogeneic Stem Cell Transplantation and Increases the Frequency of CD4 + FOXP3 + T Cells.

Generation of CD4 + Regulatory T Cells by Retroviral Transduction of CD4 + CD25 − T Cells Either with the Full-Length or with a Common Exon-2 Negative Variant of Human Foxp3.

Human CD4 + CD25 + Regulatory T Cells Effectively Control Xenogeneic-GvHD Induced by Autologous T Cells in Rag2 −/− γc −/− Immune-Deficient Mice.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only